Skip to main content.

pharmaceutical

Picture of Earle Holland
An over-the-top University of Iowa news release about the ability of herb compounds to "cure" disease proves itself to be another a case study on how not to promote university research.
Picture of Susan  Abram

The makers of popular drugs like Advair, Cymbalta, Viagra and Zoloft have physicians, psychiatrists, and medical school faculty members across California on their payrolls. Does this influence prescribing patterns?

Picture of Andrew Resignato

The Chinese call it the hundred day cough. In Spanish it is tosferina or “Bark of the Dog.” Pertussis, a.k.a. whooping cough, is a disease that many thought to be a thing of the past, but has been making a comeback for several decades now. In some cases, it has been deadly.

Picture of Nathanael Johnson

Inquiry into the FDA demanded, Medicaid cheats arrested, heart attacks more survivable and more from our Daily Briefing.

Picture of William Heisel

You don't want to be a disease mongerer, do you? Here's how to avoid it in your work.

Picture of Nathanael Johnson

Counterfeit pills, direct primary care, bogus health food claims, drug-industry science and more from our Daily Briefing.

Picture of William Heisel

The American Pain Foundation – an industry-funded promoter of painkillers - closed its doors last week amid a federal inquiry. Here's how some top-notch journalists helped make it happen.

Picture of Edwin Bender

Tips for following the money trail of vaccine exemption legislation in your state.

Picture of William Heisel

Bioethicist Leigh Turner, recently under fire from a stem cell company he criticized for ethical problems, talks about his research on medical tourism.

Picture of Angilee Shah

Medify got lots of attention at SXSW Interactive for its implications for patients -- but it could also be a great tool for reporting on medical studies.

Pages

Announcements

The nation's top infectious disease specialist will join us for a conversation with national health reporter Dan Diamond of The Washington Post. We’ll talk about the evolving threat posed by monkeypox, the current state of the COVID pandemic, and broader lessons on how we respond to emerging diseases. Sign-up here!

CONNECT WITH THE COMMUNITY

Follow Us

Facebook


Twitter

CHJ Icon
ReportingHealth